MPTP administration increases plasma levels of acute phase proteins in non-human primates (Macaca fascicularis)

Neuroscience Letters

Volumn 463, Issue 1, 2009, Pages 37-39

  De Pablos, V ^a   Barcia, C ^a   Martinez S ^b   Gomez, A ^a   Ros Bernal, F ^a   Zamarro Parra, J ^a   Soria Torrecillas, J J ^a   Hernandez J ^a   Ceron, J J ^b   Herrero, M T ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

C reactive protein (CRP); Dopamine; Haptoglobin (HP); Neuroinflammation; Neuronal degeneration; Parkinson's disease; Serum amyloid A (SAA)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; HAPTOGLOBIN; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; MACACA; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ACUTE-PHASE PROTEINS; ANIMALS; C-REACTIVE PROTEIN; DOPAMINE AGENTS; HAPTOGLOBINS; INFLAMMATION; MACACA FASCICULARIS; MALE; PARKINSON DISEASE, SECONDARY; SERUM AMYLOID A PROTEIN;

EID: 68149123496     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.069     Document Type: Article

References (31)

1. Badolato R., Wang J.M., Murphy W.J., Lloyd A.R., Michiel D.F., Bausserman L.L., Kelvin D.J., and Oppenheim J.J. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. The Journal of Experimental Medicine 180 (1994) 203-209
2. Ballou S.P., and Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4 (1992) 361-368
3. Barcia C., Bautista V., Sanchez-Bahillo A., Fernandez-Villalba E., Faucheux B., Poza y Poza M., Fernandez Barreiro A., Hirsch E.C., and Herrero M.T. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian. Journal of Neural Transmission 112 (2005) 1237-1248
4. Barcia C., de Pablos V., Bautista-Hernandez V., Sanchez-Bahillo A., Bernal I., Fernandez-Villalba E., Martin J., Banon R., Fernandez-Barreiro A., and Herrero M.T. Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration. Parkinsonism & Related Disorders 11 (2005) 435-439
5. Barcia C., Fernandez Barreiro A., Poza M., and Herrero M.T. Parkinson's disease and inflammatory changes. Neurotoxicity Research 5 (2003) 411-418
6. Barcia C., Sanchez Bahillo A., Fernandez-Villalba E., Bautista V., Poza Y.P.M., Fernandez-Barreiro A., Hirsch E.C., and Herrero M.T. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 46 (2004) 402-409
7. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., and Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neuroscience Letters 202 (1995) 17-20
8. Brochard V., Combadiere B., Prigent A., Laouar Y., Perrin A., Beray-Berthat V., Bonduelle O., Alvarez-Fischer D., Callebert J., Launay J.M., Duyckaerts C., Flavell R.A., Hirsch E.C., and Hunot S. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. The Journal of Clinical Investigation 119 (2009) 182-192
9. Brodacki B., Staszewski J., Toczylowska B., Kozlowska E., Drela N., Chalimoniuk M., and Stepien A. Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neuroscience Letters 441 (2008) 158-162
10. Drenth J.P., van der Meer J.W., and Kushner I. Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. Journal of Immunology 157 (1996) 400-404
11. Dufek M., Hamanova M., Lokaj J., Goldemund D., Rektorova I., Michalkova Z., Sheardova K., and Rektor I. Serum inflammatory biomarkers in Parkinson's disease. Parkinsonism & Related Disorders (2008)
12. Ebersole J.L., Cappelli D., Mathys E.C., Steffen M.J., Singer R.E., Montgomery M., Mott G.E., and Novak M.J. Periodontitis in humans and non-human primates: oral-systemic linkage inducing acute phase proteins. Annals of Periodontology/The American Academy of Periodontology 7 (2002) 102-111
13. Ebersole J.L., Cappelli D., Mott G., Kesavalu L., Holt S.C., and Singer R.E. Systemic manifestations of periodontitis in the non-human primate. Journal of Periodontal Research 34 (1999) 358-362
14. Faucheux B.A., Bonnet A.M., Agid Y., and Hirsch E.C. Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353 (1999) 981-982
15. Forno L.S., DeLanney L.E., Irwin I., and Langston J.W. Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey. Molecular Neurobiology 9 (1994) 163-170
16. Grunblatt E., Mandel S., and Youdim M.B. Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP. Annals of the New York Academy of Sciences 899 (2000) 262-273
17. Hirsch E.C., Breidert T., Rousselet E., Hunot S., Hartmann A., and Michel P.P. The role of glial reaction and inflammation in Parkinson's disease. Annals of the New York Academy of Sciences 991 (2003) 214-228
18. Ho G., Zhang C., and Zhuo L. Non-invasive fluorescent imaging of gliosis in transgenic mice for profiling developmental neurotoxicity. Toxicology and Applied Pharmacology 221 (2007) 76-85
19. Jensen L.E., and Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. The Biochemical Journal 334 Pt 3 (1998) 489-503
20. Jinbo T., Ami Y., Suzaki Y., Kobune F., Ro S., Naiki M., Iguchi K., and Yamamoto S. Concentrations of C-reactive protein in normal monkeys (Macaca irus) and in monkeys inoculated with Bordetella bronchiseptica R-5 and measles virus. Veterinary Research Communications 23 (1999) 265-274
21. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., and Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Annals of Neurology 46 (1999) 598-605
22. Marinkovic S., and Baumann H. Structure, hormonal regulation, and identification of the interleukin-6- and dexamethasone-responsive element of the rat haptoglobin gene. Molecular and Cellular Biology 10 (1990) 1573-1583
23. McGeer P.L., Itagaki S., Boyes B.E., and McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
24. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism & Related Disorders 10 Suppl. 1 (2004) S3-7
25. McGeer P.L., Schwab C., Parent A., and Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Annals of Neurology 54 (2003) 599-604
26. Miletich R.S., Bankiewicz K.S., Quarantelli M., Plunkett R.J., Frank J., Kopin I.J., and Di Chiro G. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys. Annals of Neurology 35 (1994) 689-697
27. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., and Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neuroscience Letters 211 (1996) 13-16
28. Mount M.P., Lira A., Grimes D., Smith P.D., Faucher S., Slack R., Anisman H., Hayley S., and Park D.S. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. Journal of Neuroscience 27 (2007) 3328-3337
29. Sipe J.D., Johns M.A., Ghezzi P., and Knapschaefer G. Modulation of serum amyloid A gene expression by cytokines and bacterial cell wall components. Advances in Experimental Medicine and Biology 243 (1988) 193-201
30. Stypula G., Kunert-Radek J., Stepien H., Zylinska K., and Pawlikowski M. Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with Parkinson's disease. Neuroimmunomodulation 3 (1996) 131-134
31. Yoshioka M., Watanabe A., Shimada N., Murata H., Yokomizo Y., and Nakajima Y. Regulation of haptoglobin secretion by recombinant bovine cytokines in primary cultured bovine hepatocytes. Domestic Animal Endocrinology 23 (2002) 425-433